2020 has not been kind to Sanofi’s flagship heartburn medication Zantac. When reports first surfaced of contamination of the medication with a known carcinogen, attention immediately turned to the labs that made ranitidine, the active ingredient in Zantac. It wasn’t until researchers discovered that Zantac could be producing the carcinogen itself that calls began for a recall of the drug. The mechanism that could lead to such an occurrence, however, has ...
Zantac, Ranitidine, NDMA, and You: What You Need to Know
Posted April 9, 2020 in Drug and Medical Device Lawsuits | Heartburn Medications and Kidney Damage | Product News and Recalls | Recall
Frequent Use of Heartburn Medications May Lead to Kidney Damage
Posted April 22, 2016 in Heartburn Medications and Kidney Damage | Product News and Recalls
A new batch of research shows that frequent and long-term use of some of the most commonly used heartburn medications may, over time, lead to kidney damage.
Drugs like Prilosec OTC, Prevacid, and Nexium fall into a class known as PPIs, or proton-pump inhibitors. The drugs work by stifling the body’s ability to produce gastric acid; one of the key factors in experiencing frequent heartburn.
Most heartburn is treated over ...
continue reading...
